Last reviewed · How we verify
NCT04459169: TEAM Red Flags
Cardiac Amyloidosis : Diagnostic Using Red Flag Signals
trial testing diagnostic algorithm in Cardiac Amyloidosis in 424 participants. Status unknown.
30 September 2021
Quick facts
| Lead sponsor | University Hospital Center of Martinique |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 424 |
| Start date | 30 September 2020 |
| Primary completion | 30 September 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 3 locations across Martinique, Guadeloupe |
Drugs / interventions tested
- diagnostic algorithm
Conditions studied
- Cardiac Amyloidosis — all drugs for Cardiac Amyloidosis →
Sponsor
University Hospital Center of Martinique
Who can join
45 and older, any sex, with Cardiac Amyloidosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cardiac amyloidosis is an increasingly contributor of degenerative cardiac diseases. However, its frequency remains underestimated, and diagnosis is often realized at late stages of the disease. A larger use of clinical and echographic Red Flag signals during routine echocardiographic examination may enhance the identification of early stage of the disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04459169
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of diagnostic algorithm
Trials testing the same drug.
- NCT04470518 — Impact of Clinical Guidance & Point-of-care CRP in Children: the ARON Project · NA · completed
Other recruiting trials for Cardiac Amyloidosis
Currently open trials in the same condition.
- NCT07232459 — [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis · recruiting
- NCT06788535 — Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis · Phase 3 · active not recruiting
- NCT06458374 — ATTR Cardiac Amyloidosis in a Selected Population · recruiting
- NCT06427304 — Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure · recruiting
- NCT06907836 — Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine · recruiting
Other University Hospital Center of Martinique trials
Trials by the same sponsor.
- NCT07206927 — Analysis of the Determinants of the Participation of Patients and Health Professionals of the University Hospital Center · not yet recruiting
- NCT06909591 — Transcultural and Psychometric Validation of the Lubben Social Network Scale in Older Adults Living in the French West I · not yet recruiting
- NCT06153589 — Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care · NA · recruiting
- NCT06365359 — Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique · recruiting
- NCT06776627 — Effectiveness of an Adapted Physical Activity Program on Improving the Health-related Quality of Life of Women With Endo · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04459169 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Center of Martinique
- Last refreshed: 17 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04459169.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing